EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.1 | alcohol dehydrogenase |
uterus |
- |
285604, 722073 |
1.1.1.105 | all-trans-retinol dehydrogenase (NAD+) |
uterus |
mRNA expression |
692959 |
1.1.1.141 | 15-hydroxyprostaglandin dehydrogenase (NAD+) |
uterus |
- |
740130 |
1.1.1.145 | 3beta-hydroxy-DELTA5-steroid dehydrogenase |
uterus |
3betaHSD VI |
389384 |
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
uterus |
- |
760868 |
1.1.1.146 | 11beta-hydroxysteroid dehydrogenase |
uterus |
expression of isozyme 11beta-HSD1 in intrauterine tissue, overview |
668424 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
uterus |
- |
699835, 739860 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
uterus |
20alpha-HSD mRNA lower expressed |
285997 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
uterus |
intercaruncular part |
670023 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
uterus |
low expression rate of AKR1C23 |
669908 |
1.1.1.149 | 20alpha-hydroxysteroid dehydrogenase |
uterus |
regulation of enzyme expression during pregnancy |
670272 |
1.1.1.184 | carbonyl reductase (NADPH) |
uterus |
- |
697262 |
1.1.1.188 | prostaglandin-F synthase |
uterus |
endometrium of repeat-breeding cows |
760315 |
1.1.1.188 | prostaglandin-F synthase |
uterus |
high activity |
687797 |
1.1.1.188 | prostaglandin-F synthase |
uterus |
PGFS mRNA and protein expression in the endometrium does not differ between pregnancy and oestrous cycle but PGFS mRNA in the myometrium increases during pregnancy both in the gravid and the non-gravid uterine horns |
706695 |
1.1.1.188 | prostaglandin-F synthase |
uterus |
the prostaglandin F synthase AKR1B1 is upregulated while prostaglandin transporter is downregulated during term labor. The amnion is more responsive than choriodecidua to stimulation with proinflammatory cytokines. The mechanisms of term and preterm labor are different, overview |
740487 |
1.1.1.188 | prostaglandin-F synthase |
uterus |
uterine expression of isoforms AKR1C3 is up-regulated postimplantation and declines prepartum. Enzyme co-localizes with 15-prostaglandin dehydrogenase |
724504 |
1.1.1.188 | prostaglandin-F synthase |
uterus |
uterine tissues at delivery |
713047 |
1.1.1.188 | prostaglandin-F synthase |
uterus |
utero/placental expression of PGFS (AKR1C3) is identified in the superficial uterine glands throughout gestation and in the trophoblast cells within the feto-maternal contact zone during placentation. Colocalization of 15-hydroxyprostaglandin dehydrogenase (HPGD) with PGFS (AKR1C3) expression. Uterine PGFS (AKR1C3) is up-regulated postimplantation and declined prepartum |
740130 |
1.1.1.27 | L-lactate dehydrogenase |
uterus |
- |
683562 |
1.1.1.284 | S-(hydroxymethyl)glutathione dehydrogenase |
uterus |
preterm and term myometrium |
763729 |
1.1.1.31 | 3-hydroxyisobutyrate dehydrogenase |
uterus |
- |
722472 |
1.1.1.315 | 11-cis-retinol dehydrogenase |
uterus |
25% mRNA expression of Rdh5 compared to liver |
690797 |
1.1.1.34 | hydroxymethylglutaryl-CoA reductase (NADPH) |
uterus |
medium expression level |
722328 |
1.1.1.36 | acetoacetyl-CoA reductase |
uterus |
very low expression of isozymes AKR1B15.1 and AKR1B15.2 |
740743 |
1.1.1.51 | 3(or 17)beta-hydroxysteroid dehydrogenase |
uterus |
taken from 10-20 days pregnant mice for enzyme extraction including the embryo |
677079 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
uterus |
- |
287205, 654934, 670033 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
uterus |
in epithelial, luminal and glandular, and in stromal cells |
675190 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
uterus |
low mRNA expression |
688007 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
uterus |
luminal and glandular epithelium |
287198 |
1.1.1.62 | 17beta-estradiol 17-dehydrogenase |
uterus |
very low expression of isozymes AKR1B15.1 and AKR1B15.2 |
740743 |
1.1.1.B40 | 11beta-hydroxysteroid dehydrogenase (NAD+) |
uterus |
- |
656372 |
1.11.1.12 | phospholipid-hydroperoxide glutathione peroxidase |
uterus |
- |
671327, 674370 |
1.11.1.12 | phospholipid-hydroperoxide glutathione peroxidase |
uterus |
Gpx4 is found in the endometrium, myometrium, blood vessels, and stroma of uterus |
764923 |
1.11.1.20 | prostamide/prostaglandin F2alpha synthase |
uterus |
- |
687797 |
1.11.1.20 | prostamide/prostaglandin F2alpha synthase |
uterus |
activity is the highest in spinal cord and brain followed by thymus, adrenal gland, heart, and genital organs |
687797 |
1.11.1.24 | thioredoxin-dependent peroxiredoxin |
uterus |
the enzyme is mainly localized in the muscle, eggs, gut wall, uterus wall and hypodermis |
756868 |
1.11.1.25 | glutaredoxin-dependent peroxiredoxin |
uterus |
- |
754093 |
1.13.11.33 | arachidonate 15-lipoxygenase |
uterus |
- |
742613 |
1.14.11.2 | procollagen-proline 4-dioxygenase |
uterus |
- |
-, 439247 |
1.14.11.65 | [histone H3]-dimethyl-L-lysine9 demethylase |
uterus |
- |
745102 |
1.14.11.66 | [histone H3]-trimethyl-L-lysine9 demethylase |
uterus |
- |
-, 745102 |
1.14.13.39 | nitric-oxide synthase (NADPH) |
uterus |
three isoforms of nitric oxide synthase are mainly localized in the uterine luminal and glandular epithelium and myometrium, and the intensity of immunostaining for inducible nitric oxide synthase and endothelial nitric oxide synthase increases gradually with temporal development of the postnatal uterus. The total nitric oxide synthase and inducible nitric oxide synthase activities are significantly increased at postnatal days 21 and 35. Although constitutive nitric oxide synthase activity is increased at postnatal day 21, it decreases subsequently at postnatal day 35. Inducible nitric oxide synthase protein expression is significantly increased at postnatal days 21 and 35 |
723884 |
1.14.13.8 | flavin-containing monooxygenase |
uterus |
- |
673313 |
1.14.14.154 | sterol 14alpha-demethylase |
uterus |
during the peri-implantation period, is selectively expressed in the uterine subluminal stroma surrounding the implanting blastocyst on day 5 of pregnancy. High level of LDM expression in the uterus decidua on days 6-8 of pregnancy. Is absent in the uterus on day 5 of pseudopregnancy |
706694 |
1.14.14.79 | docosahexaenoic acid omega-hydroxylase |
uterus |
glandular epithelial cells |
728344 |
1.14.15.15 | cholestanetriol 26-monooxygenase |
uterus |
- |
736710 |
1.14.99.1 | prostaglandin-endoperoxide synthase |
uterus |
- |
697628 |
1.14.99.1 | prostaglandin-endoperoxide synthase |
uterus |
in the stroma of endometrial epithelium |
684980 |
1.2.1.12 | glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) |
uterus |
- |
656745 |
1.2.1.18 | malonate-semialdehyde dehydrogenase (acetylating) |
uterus |
- |
690142 |
1.2.1.3 | aldehyde dehydrogenase (NAD+) |
uterus |
- |
690142 |
1.2.1.31 | L-aminoadipate-semialdehyde dehydrogenase |
uterus |
- |
690142 |
1.2.1.36 | retinal dehydrogenase |
uterus |
- |
655695, 677080, 690142 |
1.2.1.41 | glutamate-5-semialdehyde dehydrogenase |
uterus |
- |
690142 |
1.2.1.47 | 4-trimethylammoniobutyraldehyde dehydrogenase |
uterus |
- |
690142 |
1.2.1.5 | aldehyde dehydrogenase [NAD(P)+] |
uterus |
- |
690142 |
1.21.99.3 | thyroxine 5-deiodinase |
uterus |
endometrial gland |
659569 |
1.21.99.3 | thyroxine 5-deiodinase |
uterus |
pregnant |
733907 |
1.3.1.70 | DELTA14-sterol reductase |
uterus |
LBR |
672378 |
1.3.99.5 | 3-oxo-5alpha-steroid 4-dehydrogenase (acceptor) |
uterus |
type 1 5alpha-reductase is predominantly expressed in the uterus |
662726 |
1.4.3.13 | protein-lysine 6-oxidase |
uterus |
- |
-, 764665 |
1.4.3.13 | protein-lysine 6-oxidase |
uterus |
LOXL2, LOX, LOXL |
658189 |
1.4.3.5 | pyridoxal 5'-phosphate synthase |
uterus |
2.9% of the activity in liver |
655483 |
1.6.3.1 | NAD(P)H oxidase (H2O2-forming) |
uterus |
- |
711688 |
1.6.99.1 | NADPH dehydrogenase |
uterus |
cyclic changes dependent on the estrous cycle. Changes observed mostly in the luminal epithelium and some endometrial glands. Localization and correlation between NADPH-diaphorase and nitric oxide synthase isoforms |
672986 |
1.8.1.9 | thioredoxin-disulfide reductase |
uterus |
- |
658795 |
1.8.3.2 | thiol oxidase |
uterus |
epithelial cells |
393065 |
2.1.1.2 | guanidinoacetate N-methyltransferase |
uterus |
low enzyme level |
485207 |
2.1.1.72 | site-specific DNA-methyltransferase (adenine-specific) |
uterus |
- |
719373 |
2.3.1.1 | amino-acid N-acetyltransferase |
uterus |
- |
486070 |
2.3.1.255 | N-terminal amino-acid Nalpha-acetyltransferase NatA |
uterus |
- |
-, 756675 |
2.3.1.51 | 1-acylglycerol-3-phosphate O-acyltransferase |
uterus |
expression of AGPAT7 |
673280 |
2.3.1.57 | diamine N-acetyltransferase |
uterus |
- |
487259, 487260 |
2.3.1.67 | 1-alkylglycerophosphocholine O-acetyltransferase |
uterus |
- |
487392 |
2.3.1.B43 | protein-lysine desuccinylase (NAD+) |
uterus |
- |
755970 |
2.3.2.13 | protein-glutamine gamma-glutamyltransferase |
uterus |
- |
487858 |
2.3.2.2 | gamma-glutamyltransferase |
uterus |
- |
487920 |
2.3.2.27 | RING-type E3 ubiquitin transferase |
uterus |
- |
692490 |
2.4.1.109 | dolichyl-phosphate-mannose-protein mannosyltransferase |
uterus |
- |
723102 |
2.4.1.11 | glycogen(starch) synthase |
uterus |
GYS1 |
-, 720446 |
2.4.1.145 | alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
uterus |
- |
703913 |
2.4.1.152 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase |
uterus |
- |
687115 |
2.4.1.152 | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase |
uterus |
transcript of FUT6 mRNA detected |
639521 |
2.4.1.17 | glucuronosyltransferase |
uterus |
isozyme UGT1A1 |
659315 |
2.4.1.17 | glucuronosyltransferase |
uterus |
isozyme UGT2B7 |
659571 |
2.4.1.174 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase |
uterus |
- |
638345 |
2.4.1.175 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase |
uterus |
- |
638345, 659262 |
2.4.1.212 | hyaluronan synthase |
uterus |
- |
657784 |
2.4.1.255 | protein O-GlcNAc transferase |
uterus |
- |
489611 |
2.4.1.275 | neolactotriaosylceramide beta-1,4-galactosyltransferase |
uterus |
- |
715438 |
2.4.1.40 | glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase |
uterus |
- |
489149 |
2.4.1.40 | glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase |
uterus |
A-type enzyme expression |
658843 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
uterus |
- |
489182, 657716 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
uterus |
enzyme form pp-GalNAc-T15 |
658739 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
uterus |
highest levels of GALNTL5 mRNA and protein occur in the uterine horn and oviductal ampulla and the lowest in the uterine cervix and oviductal infundibulum. GALNTL5 protein is mainly located in luminal and glandular epithelial cells of the uterus and oviduct |
755794 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
uterus |
isozyme T4 |
489199 |
2.4.1.41 | polypeptide N-acetylgalactosaminyltransferase |
uterus |
ppGaNTase-T9, less amount |
489182 |
2.4.1.65 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase |
uterus |
adult tissue with moderate level |
704613 |
2.4.1.69 | type 1 galactoside alpha-(1,2)-fucosyltransferase |
uterus |
- |
489359 |